Skip to search formSkip to main contentSkip to account menu

simendan

Known as: ((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono)propanedinitrile, Mesoxalonitrile (+/-)-(P-(1,4,5,6-Tetrahydro-4-Methyl-6-Oxo-3-Pyridazinyl)Phenyl)Hydrazone 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Herein, the enantiomeric separation of simendan by HPLC with ultraviolet detection method using polysaccharide-based chiral… 
2019
2019
OBJECTIVE Simendan is a calcium sensitizer that enhances myocardial contractility but does not affect ventricular diastole… 
2017
2017
Abstract Maintaining adequate quality of life (QoL) is an important therapeutic objective for patients with advanced heart… 
Review
2014
Review
2014
Levosimendan, the active enantiomer of simendan, is a calcium sensitizer developed for treatment of decompensated heart failure… 
2004
2004
The chiral separation of simendan enantiomers using capillary electrophoresis was studied with beta-cyclodextrin (beta-CD) as… 
1996
1996
rac-Simendan, (+/-)-(R,S)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)-phenyl ] hydrazono]propanedinitrile, and the… 
Highly Cited
1994
Highly Cited
1994
Complexation between the linear maltodextrin oligosaccharides and certain enantiomeric compounds of pharmaceutical interest in… 
1994
1994
To assess pharmacokinetics and correlation of pharmacokinetics and pharmacodynamics of simendan, a new calcium‐sensitizing… 
1994
1994
SummarySimendan is a novel cardiotonic drug with mixed properties, including calcium sensitization. Simendan was given…